From Presage, a Hutch Spinoff, Raises $3M From Angels to Boost Cancer Drug Hit Rate:

jimolsonhutch
jimolsonhutch

Jim Olson is the founder of Presage Biosciences, a researcher at the Fred Hutchinson Cancer Research Center, and a physician at Seattle Children’s Hospital